Postmenopausal bleeding due to a Cu-7 intrauterine device retained for thirty years

Journal of the Society of Laparoendoscopic Surgeons

Volumn 16, Issue 2, 2012, Pages 329-332

  Wagner, Corey A ^a,b   Gimpelson, Richard J ^a  

^a ST JOHN S MERCY MEDICAL CENTER   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hysteroscopic removal of IUD; Intrauterine device; Post menopausal bleeding; Retained IUD; Ultrasound

Indexed keywords

ARTICLE; CASE REPORT; ECHOGRAPHY; FEMALE; HUMAN; HYSTEROSCOPY; INTRAUTERINE CONTRACEPTIVE DEVICE; METRORRHAGIA; MIDDLE AGED; POSTMENOPAUSE; THREE DIMENSIONAL IMAGING; UTERUS;

FEMALE; HUMANS; HYSTEROSCOPY; IMAGING, THREE-DIMENSIONAL; INTRAUTERINE DEVICES; METRORRHAGIA; MIDDLE AGED; POSTMENOPAUSE; UTERUS;

EID: 84869775165     PISSN: 10868089     EISSN: 19383797     Source Type: Journal    
DOI: 10.4293/108680812X13427982376743     Document Type: Article

References (23)

1. Katz VL, Lentz GM, Lobo RA, Gershenson DM. Comprehensive Gynecology, 5th ed. Philadelphia (PA): Mosby Elsevier, 2007; 157-158.
2. Schorge, JO, Schaffer JI, Halvorson LM, et al. Williams Gy-necology, 1st ed. New York (NY): McGraw Hill Medical 2008; 174-196.
3. Stovall TG, Photopulos GJ, Poston WN, et al. Pipelle endo-metrial sampling in patient with known endometrial cancer. Obstet Gynecol. 1991;77:954-956.
4. Ferry J, Farnsworth A, Webster M, Wren B. The efficacy of the Pipelle endometrial biopsy in detecting endometrial carcinoma. Aust N Z J Obstet Gynaecol. 1993;33:76-78.
5. Guido RS, Kanbour-Shakir A, Rulin MC, Christopherson WA. Pipelle endometrial sampling. Sensitivity in the detection of endometrial cancer. J Reprod Med. 1995;40:553-555.
6. Zorlu CG, Cobanoglu O, Isik AZ, et al. Accuracy of Pipelle endometrial sampling in endometrial carcinoma. Gynecol Obstet Invest. 1994;38:272-275.
7. Goldstein SR. Modern evaluation of the endometrium. Obstet Gynecol. 2010;116:168-176.
8. Gimpelson RJ. Panoramic hysteroscopy with directed biopsies vs. dilation and curettage for accurate diagnosis. J Reprod Med. 1984;29(8):757-758.
9. Gimpelson RJ, Rappold HO. A comparative study between panoramic hysteroscopy with directed biopsies and dilation and curettage. Am J Obstet Gynecol. 1988;158(3):489-492.
10. Ronnett B, Kurman R. Presursor Lesions of Endometrial Carcinoma. In Kurman R, ed. Blaustein's Pathology of the Female Genital Tract. New York (NY): Springer-Verlag 2002;482.
11. Hacker NF, Moore JG. Essentials of Obstetrics and Gynecol-ogy, 3rd ed. Philadelphia (PA): WB Saunders 1998;635.
12. Elsandabesee D, Greenwood P. The performance of Pipelle endometrial sampling in a dedicated postmenopausal bleeding clinic. J Obstet Gynecol. 2005;25:32-34.
13. Gupta JK, Chien PF, Voit D, et al. Ultrasonographic endo-metrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis. Acta Obstet Gynecol Scand. 2002;81:799-816.
14. Smith-Bindman R, Kerlikowske K, Feldstein VA, et al. Endo-vaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA. 1998;280:1510-1517.
15. Hong BK, Jeng CL, Huang Sh, et al. Sonographic and clinical findings of granulosa cell tumor. Zhonghua Yi Xue Za Zhi (Taipei). 1996;57(3):214-218.
16. Patlas M, Rosen B, Chapman W, Wilson SR. Sonographic diagnosis primary malignant tumors of the fallopian tube. Ultrasound Q. 2004;20(2):59-64.
17. Dah-ching Ding, Senzan Hsu, Ta-Wei Chu. Retained intra-uterine device as an unusual cause of postmenopausal bleeding. Tzu Chi Med J. 2006;18(5):389-391.
18. Pisal N, Mammo M. Case-series report: management of post-menopausal bleeding in the presence of an intrauterine device. Contraception. 2002;66:383-384.
19. Tapia JE, von Felten A, Hauser GA. Low-carat gold intrauter-ine device for contraception 44 years in the uterus. Zentralbl Gynakol. 1984;106:337-340.
20. Farghaly SA, Mathie JG. Retained Gräfenberg ring for 39 years discovered during abdominal hysterectomy. Aust N Z J Obstet Gynaecol. 1980;20:248-250.
21. Sozen I, Morgan K, Shannon JS. Postmenopausal bleeding secondary to a Dalkon Shield retained for 33 years: a case report. J Reprod Med. 2005;50:216-218.
22. Farr G. The IUD: will its future always be crippled by its past? Family Plan World. 1993;3(4):5, 26.
23. Mosher WD, Jones J. Use of contraception in the United States: 1982-2008. Vital Health Stat 23. 2010;(29):17-19.